Search details
1.
Handling missing data when estimating causal effects with Targeted Maximum Likelihood Estimation.
Am J Epidemiol
; 2024 Feb 22.
Article
in English
| MEDLINE | ID: mdl-38400653
2.
When should factorial designs be used for late-phase randomised controlled trials?
Clin Trials
; 21(2): 162-170, 2024 04.
Article
in English
| MEDLINE | ID: mdl-37904490
3.
Increasing non-cosmetic exposure and sensitization to isothiazolinones require action for prevention: Review.
Contact Dermatitis
; 90(5): 445-457, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38382085
4.
Phases of methodological research in biostatistics-Building the evidence base for new methods.
Biom J
; 66(1): e2200222, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-36737675
5.
Comment on Oberman & Vink: Should we fix or simulate the complete data in simulation studies evaluating missing data methods?
Biom J
; 66(1): e2300085, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37823668
6.
A comparison of strategies for selecting auxiliary variables for multiple imputation.
Biom J
; 66(1): e2200291, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38285405
7.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol
; 24(7): 783-797, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37414011
8.
The Personalised Randomized Controlled Trial: Evaluation of a new trial design.
Stat Med
; 42(8): 1156-1170, 2023 04 15.
Article
in English
| MEDLINE | ID: mdl-36732886
9.
Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes.
Stat Med
; 42(8): 1127-1138, 2023 04 15.
Article
in English
| MEDLINE | ID: mdl-36661242
10.
Measuring the performance of prediction models to personalize treatment choice.
Stat Med
; 42(8): 1188-1206, 2023 04 15.
Article
in English
| MEDLINE | ID: mdl-36700492
11.
A new approach to evaluating loop inconsistency in network meta-analysis.
Stat Med
; 42(27): 4917-4930, 2023 11 30.
Article
in English
| MEDLINE | ID: mdl-37767752
12.
How important is the linearity assumption in a sample size calculation for a randomised controlled trial where treatment is anticipated to affect a rate of change?
BMC Med Res Methodol
; 23(1): 274, 2023 11 21.
Article
in English
| MEDLINE | ID: mdl-37990159
13.
Using modified intention-to-treat as a principal stratum estimator for failure to initiate treatment.
Clin Trials
; 20(3): 269-275, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36916466
14.
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.
Clin Trials
; 20(6): 594-602, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37337728
15.
Occupational hand dermatitis secondary to methacrylates-The 'manual tray' sign.
Contact Dermatitis
; 88(2): 152-153, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36258285
16.
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population : A Systematic Review and Dose-Response Meta-analysis.
Ann Intern Med
; 175(11): 1560-1571, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36252247
17.
artcat: Sample-size calculation for an ordered categorical outcome.
Stata J
; 23(1): 3-23, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-37155554
18.
artbin: Extended sample size for randomized trials with binary outcomes.
Stata J
; 23(1): 24-52, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-37461744
19.
Introducing the Treatment Hierarchy Question in Network Meta-Analysis.
Am J Epidemiol
; 191(5): 930-938, 2022 03 24.
Article
in English
| MEDLINE | ID: mdl-35146500
20.
Network meta-analysis of rare events using penalized likelihood regression.
Stat Med
; 41(26): 5203-5219, 2022 11 20.
Article
in English
| MEDLINE | ID: mdl-36054668